'Data-Rich' Sources Can ID Niaspan Class, 3rd Circ. Told
By Bryan Koenig · January 21, 2022, 5:57 PM EST
Antitrust advocacy groups want the Third Circuit to reverse a Pennsylvania federal judge's decision refusing to certify a class of end-payors alleging improper pay-for-delay settlements between AbbVie and Teva Pharmaceuticals delaying...
To view the full article, register now.